Early Increase of Ca 19-9 In Advanced Pancreatic Cancer Receiving Folfirinox Is It a Sign of Efficacy ?

doi:N/A

submission@lmj.com

FAQs

Journal Medical Libanais

Home
- Archives
- Articles In-Press
- Instructions of Authors
Submit Article

Cite

APA

Tabch, S., Kourie, H. R., Farhat, F. & Kattan, J. (2019). Early Increase of Ca 19-9 In Advanced Pancreatic Cancer Receiving Folfirinox Is It a Sign of Efficacy ?. Journal Medical Libanais, 64(1), None-None.

MLA

Tabch, Samer, et al. "Early Increase of Ca 19-9 In Advanced Pancreatic Cancer Receiving Folfirinox Is It a Sign of Efficacy ?." Journal Medical Libanais 64.1 (2019): None-None.

Chicago

Tabch, Samer, Hampig R. Kourie, Fadi Farhat and Joseph Kattan. "Early Increase of Ca 19-9 In Advanced Pancreatic Cancer Receiving Folfirinox Is It a Sign of Efficacy ?." Journal Medical Libanais 64, no. 1 (2019): None-None.

Harvard

Tabch, S., Kourie, H. R., Farhat, F. and Kattan, J. (2019) 'Early Increase of Ca 19-9 In Advanced Pancreatic Cancer Receiving Folfirinox Is It a Sign of Efficacy ?' Journal Medical Libanais 64(1), pp. None-None.

Vancouver

Tabch S, Kourie HR, Farhat F, Kattan J. Early Increase of Ca 19-9 In Advanced Pancreatic Cancer Receiving Folfirinox Is It a Sign of Efficacy ?. Journal Medical Libanais. 2019 ;64(1):None-None.